from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1957/-

LFCtreatmentdescriptionclass of inhibitor

2.020

Amikacinug/mL Amikacintranslation

0.763

Cap5-10ug/mL Capreomycintranslation

1.070

Rox10-50 ug/mL Roxithromycintranslation

2.400

SM2-5 ug/mL Streptomycintranslation

0.351

Tet5-10 ug/mL Tetracyclinetranslation

-0.123

Rif0.2-5ug/mL Rifampicintranscription

0.006

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.262

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.215

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.139

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.222

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.131

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.459

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.578

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.848

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.150

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.035

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.293

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.517

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.981

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.430

KCN5-20 ug/mL Potassium cyaniderespiration

-0.555

NaN30.2-2 mM Sodium aziderespiration

0.094

Nigericin50 uM Nigericinrespiration

-0.620

TRC10-150 ug/mL Triclosanrespiration

-0.635

TRZ10-25 ug/mL Thioridazinerespiration

2.893

Valinomycin0.5-10 uM Valinomycinrespiration

0.552

ZnSO42 mM ZnSO4respiration

0.591

menadione6-10 ug/mL Menadionerespiration

-0.003

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.277

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.055

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.544

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.510

NRP_1Non-replicating persistence stage 1dosRassociated

0.101

Amp0.2mg/mL AmpicillincellWall

0.042

Cephalexin20-100 ug/mL CephalexincellWall

0.001

Cerulenin0.32-5 ug/mL CerulenincellWall

0.244

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.122

EMB10-20 ug/mL EthambutolcellWall

-0.534

Eta12-40 ug/mL EthionamidecellWall

-0.783

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.111

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.232

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.132

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.397

BZA0.12 mg/mL BenzamidearomaticAmides

-0.550

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.708

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.368

H2O24 mM hydrogen peroxideDNAdamaging

1.081

Levo10 ug/mL LevofloxacinDNAdamaging

0.585

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.777

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.922

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.855

UVUV-irradiationDNAdamaging

-0.298

ARP41-4 ug/mL Antitubercular compound ARP4?

0.214

Antimycin12.5-50 ug/mL Antimycin A?

0.272

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.218

PA_110-50 ug/mL Antitubercular compound PA-1?

0.482

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.168

PA8240.2-2 ug/mL PA-824?

-0.517

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.597

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.122

Verapamil50 uM Verapamil?

0.136

mercaptoethanol2 mM 2-Mercaptoethanol?

0.545

methoxatin10-20 ug/mL Methoxatin?